Market Overview

Jim Cramer Advises His Viewers On Teva, AT&T And More

Related TEVA
Corcept Therapeutics Is 'Fairly Valued,' Stifel Says In Downgrade
Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended
Teva bull boosts price target (Seeking Alpha)
Related SGEN
10 Biggest Price Target Changes For Monday
Benzinga's Top Upgrades, Downgrades For June 11, 2018
What Does Breakthrough Therapy Designation Really Mean For My Company? (Seeking Alpha)

On CNBC's "Mad Money Lightning Round", Jim Cramer said that he'ss not crazy about Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA). He added that investors who really want to buy it, should wait for Allergan plc Ordinary Shares (NYSE: AGN) to sell its stake in the company.

Cramer thinks that Seattle Genetics, Inc. (NASDAQ: SGEN) should be bought.

Walgreens Boots Alliance Inc (NASDAQ: WBA) is going to trade lower, when, Inc. (NASDAQ: AMZN) enters its business, thinks Cramer. He is tempted, but he wouldn't buy it. He would wait.

Benchmark Electronics, Inc. (NYSE: BHE) has a lot of cool devices and manufacturing designs, said Cramer. He likes the stock and he would buy it, but he believes it isn't cheap.

Cramer isn't a buyer of Snap Inc (NYSE: SNAP). He would wait until all the sellers clean out.

With all the changes the company is making, AT&T Inc. (NYSE: T) is a buy, said Cramer.

Posted-In: CNBC mad money Lightning Round Jim CramerMedia


Related Articles (AMZN + AGN)

View Comments and Join the Discussion!